Lexogen and Bluebee Partner to Bring the SLAMseq Metabolic RNA Sequencing Data Analysis Pipeline to the Users

Lexogen and Bluebee launch SLAMdunk data analysis pipeline RIJSWIJK, The Netherlands and Vienna, Austria — November 10, 2017 — Bluebee, a company driving genomic data-driven medicine, and Lexogen a company enabling the analysis of the complete transcriptome, announce the successful integration of the SLAMdunk pipeline on Bluebee’s private cloud-based platform, making it available to analyze data generated by... Read more

Illumina Names Gary S. Guthart, Ph.D., to its Board of Directors, Adding Decades of Leadership Experience in Healthcare

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today that Gary S. Guthart will join the company’s Board of Directors on December 1, 2017. Dr. Guthart is President and Chief Executive Officer of Intuitive Surgical, a global leader in the field of robotic-assisted minimally invasive surgery. Dr. Guthart joined Intuitive Surgical in April 1996 and has served... Read more

New England Biolabs® Launches NEBNext® Ultra™ II FS Kit for Robust Enzyme-based DNA Fragmentation and Library Preparation with as Little as 100 pg of Input DNA

Novel single-tube enzymatic fragmentation technology simplifies library preparation, minimizing sample loss Ipswich, MA, USA (November 7, 2017) — New England Biolabs (NEB®) today announced the release of the NEBNext Ultra II FS DNA Library Prep Kit for next generation sequencing (NGS). This new kit employs a novel enzymatic fragmentation system that combines fragmentation, end repair and... Read more

Seven Bridges Leads Public-Private Partnership to Develop New Data Ecosystem for NIH

November 6, 2017 Consortium will build cloud-based data resources, tools, and interoperable standards, giving researchers simultaneous access to biomedical datasets from across the National Institutes of Health CAMBRIDGE, Mass., November 06, 2017 – Seven Bridges, the leading biomedical data analysis company, today announced that it has been selected by the National Institutes of Health (NIH) to support... Read more

SeqLL Installs true Single Molecule Sequencing (tSMS®) Instrument to Support Oncology Research by Dr. David Ting, MD at the Harvard-MGH Cancer Center

November 03, 2017 07:45 AM Pacific Daylight Time WOBURN, Mass.–(BUSINESS WIRE)–SeqLL, LLC announced today that it has installed a true Single Molecule Sequencing (tSMS) Instrument at the Harvard-MGH Cancer Center to support oncology research conducted by Dr. David Ting, MD. Dr. Ting is Assistant Professor of Medicine at Harvard Medical School and a medical oncologist... Read more

Pacific Biosciences Appoints Kathy Ordoñez as Chief Commercial Officer

MENLO PARK, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:PACB) announced today that Kathy Ordoñez has been named Chief Commercial Officer and Executive Vice President. Ms. Ordoñez brings more than thirty years of experience in the life sciences and diagnostics industries, with senior roles at Hoffmann-La Roche, Celera, Quest Diagnostics and... Read more

Zymo Research and VWR Team Up in Strategic Supplier Partnership

Zymo’s DNA Purification Products to be Sold through VWR’s North American Distribution Channels IRVINE, Calif., Oct. 31, 2017 /PRNewswire/ — The management at Zymo Research Corp. announced today a joint agreement with VWR to sell and distribute Zymo Research’s DNA purification, RNA extraction, microbiomic analysis, and epigenetics products throughout North America. VWR (NASDAQ:VWR), headquartered in Radnor, PA is the leading, global, independent provider of products, services,... Read more

BD Breaks Ground on $60 Million Expansion of Nebraska Manufacturing Facility

COLUMBUS, Neb., Oct. 25, 2017 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, was joined today by Gov. Pete Ricketts and other state and local leaders to break ground on a $60 million upgrade of its Columbus-East facility. The 69,000 sq. ft. expansion will transform the Columbus-East facility into... Read more

QIAGEN and ICMP launch next-generation DNA testing solutions for identifying missing persons

The Hague, 24 October 2017 – The International Commission on Missing Persons (ICMP) today announced the launch of a cutting-edge next-generation sequencing (NGS) workflow created in collaboration with QIAGEN N.V. for ICMP’s missing persons DNA identification laboratory in The Hague. The solution integrates QIAGEN’s GeneReader NGS System and spans all aspects of the DNA laboratory workflow, from... Read more

Canadian Patent Office to Grant MilliporeSigma’s Patent Application for CRISPR Technology

News Release October 23, 2017 Your Contact: Karen Tiano +1 978 495 0093 Patent covers successful integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR First patent allowance for MilliporeSigma’s CRISPR technology in North America Related patent application awards by European and Australian Patent Offices already received; similar patents pending... Read more